Victory Capital Management
GBT

Victory Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Victory Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,200
Closed -$490K – 2781
2022
Q3 		$490K Buy
7,200
+66
+0.9% +$3.64K ﹤0.01% 2065
2022
Q2 		$228K Sell
7,134
-18
-0.3% -$527 ﹤0.01% 2313
2022
Q1 		$220K Sell
7,152
-536
-7% -$16K ﹤0.01% 2390
2021
Q4 		$225K Buy
+7,688
New +$238K ﹤0.01% 2457
2021
Q3 		– Sell
-7,457
Closed -$261K – 2877
2021
Q2 		$261K Buy
7,457
+490
+7% +$19.1K ﹤0.01% 2463
2021
Q1 		$284K Buy
6,967
+31
+0.4% +$1.43K ﹤0.01% 2417
2020
Q4 		$300K Buy
6,936
+1,375
+25% +$67.8K ﹤0.01% 2285
2020
Q3 		$307K Sell
5,561
-178
-3% -$11.3K ﹤0.01% 2153
2020
Q2 		$362K Sell
5,739
-6,905
-55% -$474K ﹤0.01% 2100
2020
Q1 		$646K Buy
12,644
+3,741
+42% +$251K ﹤0.01% 2005
2019
Q4 		$708K Buy
8,903
+1,895
+27% +$112K ﹤0.01% 1858
2019
Q3 		$340K Buy
+7,008
New +$365K ﹤0.01% 2029

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's GBT Position: Q4 2022 in Review

Victory Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 7,200 shares — an estimated $490K sold.

Victory Capital Management first reported a position in GBT in Q3 2019 and held it in 12 quarters. The position peaked at $708K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Victory Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 7,200 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $490K.
  • Victory Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 12 quarters.
  • Victory Capital Management's Global Blood Therapeutics, Inc. position peaked at $708K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.